Skip to main content
Earnings Labs
Adial Pharmaceuticals, Inc. logo

Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ·Healthcare·Biotechnology

$3.79

+3.57%

Mkt Cap $1.65M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$7.00

Range $6.00$8.00

Implied Upside

+84.9%

Consensus $7.00 vs current $3.79